These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Electrical storm in patients with an implanted defibrillator: a matter of definition. Israel CW, Barold SS. Ann Noninvasive Electrocardiol; 2007 Oct; 12(4):375-82. PubMed ID: 17970963 [Abstract] [Full Text] [Related]
3. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy. Yin K, Ding L, Hua W, Zhang S. Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825 [Abstract] [Full Text] [Related]
4. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Bonelli P, Patani F, Cupido C, Devecchi C, Accogli M, Occhetta E, Santangelo L, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511 [Abstract] [Full Text] [Related]
5. [Electrical storm in ICD patients: prevention and treatment]. Zarse M, Bogossian H, Lemke B. Herzschrittmacherther Elektrophysiol; 2014 Jun; 25(2):66-72. PubMed ID: 24823469 [Abstract] [Full Text] [Related]
6. [Management of electrical storm in implantable cardioverter-defibrillator recipients]. Santomauro M, Duilio C, Tecchia LB, Di Mauro P, Iapicca G, Auricchio L, Filardi PP. G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):37S-41S. PubMed ID: 21416825 [Abstract] [Full Text] [Related]
7. Etiology and Programming Effects on Shock Efficacy in ICD Recipients. Bertomeu-González V, Moreno-Arribas J, Castillo-Castillo J, Martínez-Ferrer J, Viñolas X, Rodríguez A, Díaz-Infante E, Fernández-Lozano I, Alzueta J, Fontenla A. Pacing Clin Electrophysiol; 2016 Jan; 39(1):73-80. PubMed ID: 26450114 [Abstract] [Full Text] [Related]
8. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. AbdelWahab A, Sapp J. Curr Cardiol Rep; 2017 Sep 13; 19(11):105. PubMed ID: 28900864 [Abstract] [Full Text] [Related]
9. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial. Gasparini M, Lunati MG, Proclemer A, Arenal A, Kloppe A, Martínez Ferrer JB, Hersi AS, Gulaj M, Wijffels MCE, Santi E, Manotta L, Varma N. JACC Clin Electrophysiol; 2017 Nov 13; 3(11):1275-1282. PubMed ID: 29759624 [Abstract] [Full Text] [Related]
10. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up. Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C. Int Heart J; 2006 Sep 13; 47(5):763-73. PubMed ID: 17106147 [Abstract] [Full Text] [Related]
11. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M. Europace; 2012 Feb 13; 14(2):224-9. PubMed ID: 21946820 [Abstract] [Full Text] [Related]
12. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. Kleemann T, Strauss M, Kouraki K, Zahn R. Europace; 2015 Jul 13; 17(7):1068-75. PubMed ID: 25687746 [Abstract] [Full Text] [Related]
13. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Guerra F, Shkoza M, Scappini L, Flori M, Capucci A. Europace; 2014 Mar 13; 16(3):347-53. PubMed ID: 24096960 [Abstract] [Full Text] [Related]
14. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD. J Am Coll Cardiol; 1999 Jan 13; 33(1):24-32. PubMed ID: 9935004 [Abstract] [Full Text] [Related]
15. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Karim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A. J Cardiovasc Electrophysiol; 2004 Nov 13; 15(11):1265-70. PubMed ID: 15574176 [Abstract] [Full Text] [Related]
18. Electrical storm and heart failure worsening in implantable cardiac defibrillator patients. Guerra F, Flori M, Bonelli P, Patani F, Capucci A. Europace; 2015 Feb 24; 17(2):247-54. PubMed ID: 25345831 [Abstract] [Full Text] [Related]
19. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A, Husser D, Cannom DS. Am J Cardiovasc Drugs; 2005 Feb 24; 5(6):371-8. PubMed ID: 16259525 [Abstract] [Full Text] [Related]
20. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MA, Akiyama T, Baessler C, Anderson JL. J Am Coll Cardiol; 1999 Aug 24; 34(2):325-33. PubMed ID: 10440140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]